We have funded multiple studies run by the Exeter IBD and Pharmacogenetics Research Group – headed up by Dr Tariq Ahmad, Consultant Gastroenterologist at the Royal Devon and Exeter. Their work brings hope that personalised medicine is not too far into the future, and we want to help with these Read more…
You may remember that we announced our £60,000 investment into the personalised anti-TNF therapy in Crohn’s disease study (PANTS), last year. Although anti-TNF drugs have given new hope for people with Crohn’s Disease and Ulcerative Colitis, and provided an important treatment option, they do not work in some patients. The Read more…
Personalised medicine is a term that has seen a major increase in interest and popularity recently, but I am here to tell you, the potential benefits for IBD patients could be a major game changer! Cure Crohn’s Colitis have invested £60,000 into a project which has the potential to predict an Read more…